These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11743514

  • 1. Gaucher disease with pulmonary involvement in a 6-year-old girl: report of resolution of radiographic abnormalities on increasing dose of imiglucerase.
    Lee SY, Mak AW, Huen KF, Lam ST, Chow CB.
    J Pediatr; 2001 Dec; 139(6):862-4. PubMed ID: 11743514
    [Abstract] [Full Text] [Related]

  • 2. [High dose of enzyme replacement therapy was successful for the pulmonary involvement in a case of type 2 Gaucher disease].
    Arai N, Uematsu M, Abe Y, Fukuyo N, Wakusawa K, Kikuchi A, Sakamoto O, Ohura T, Tsuchiya S.
    No To Hattatsu; 2010 Jan; 42(1):45-9. PubMed ID: 23858612
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary involvement in adult Gaucher's disease: high resolution CT appearance.
    Aydin K, Karabulut N, Demirkazik F, Arat A.
    Br J Radiol; 1997 Jan; 70():93-5. PubMed ID: 9059303
    [Abstract] [Full Text] [Related]

  • 4. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
    Heitner R, Arndt S, Levin JB.
    S Afr Med J; 2004 Aug; 94(8):647-51. PubMed ID: 15352589
    [Abstract] [Full Text] [Related]

  • 5. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [Abstract] [Full Text] [Related]

  • 6. Glucocerebrosidase treatment of type I Gaucher disease with severe pulmonary involvement.
    Pelini M, Boice D, O'Neil K, LaRocque J.
    Ann Intern Med; 1994 Aug 01; 121(3):196-7. PubMed ID: 8017746
    [No Abstract] [Full Text] [Related]

  • 7. Alglucerase treatment of type 1 Gaucher disease with pulmonary involvement.
    Martinez Odrizola P, Ferrero O, Jauregui I, Miguel F.
    Respir Med; 1998 Dec 01; 92(12):1370-2. PubMed ID: 10197233
    [No Abstract] [Full Text] [Related]

  • 8. Dosage-response in the treatment of Gaucher disease by enzyme replacement therapy.
    Beutler E.
    Blood Cells Mol Dis; 2000 Aug 01; 26(4):303-6. PubMed ID: 11042031
    [No Abstract] [Full Text] [Related]

  • 9. Individualization of long-term enzyme replacement therapy for Gaucher disease.
    Andersson HC, Charrow J, Kaplan P, Mistry P, Pastores GM, Prakash-Cheng A, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, International Collaborative Gaucher Group U.S. Regional Coordinators.
    Genet Med; 2005 Feb 01; 7(2):105-10. PubMed ID: 15714077
    [Abstract] [Full Text] [Related]

  • 10. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
    Rosenthal DI, Doppelt SH, Mankin HJ, Dambrosia JM, Xavier RJ, McKusick KA, Rosen BR, Baker J, Niklason LT, Hill SC.
    Pediatrics; 1995 Oct 01; 96(4 Pt 1):629-37. PubMed ID: 7567322
    [Abstract] [Full Text] [Related]

  • 11. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
    Wenstrup RJ, Kacena KA, Kaplan P, Pastores GM, Prakash-Cheng A, Zimran A, Hangartner TN.
    J Bone Miner Res; 2007 Jan 01; 22(1):119-26. PubMed ID: 17032149
    [Abstract] [Full Text] [Related]

  • 12. Lung involvement and enzyme replacement therapy in Gaucher's disease.
    Goitein O, Elstein D, Abrahamov A, Hadas-Halpern I, Melzer E, Kerem E, Zimran A.
    QJM; 2001 Aug 01; 94(8):407-15. PubMed ID: 11493717
    [Abstract] [Full Text] [Related]

  • 13. Resolution of a proximal humeral defect in type-1 Gaucher disease by enzyme replacement therapy.
    Pastores GM, Hermann G, Norton K, Desnick RJ.
    Pediatr Radiol; 1995 Aug 01; 25(6):486-7. PubMed ID: 7491212
    [Abstract] [Full Text] [Related]

  • 14. Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months.
    Pastores GM, Sibille AR, Grabowski GA.
    Blood; 1993 Jul 15; 82(2):408-16. PubMed ID: 8392397
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary hypertension in Gaucher's disease.
    Pastores GM, Miller A.
    Lancet; 1998 Aug 15; 352(9127):580. PubMed ID: 9716094
    [No Abstract] [Full Text] [Related]

  • 16. Enzyme replacement in Gaucher disease.
    Beutler E.
    PLoS Med; 2004 Nov 15; 1(2):e21. PubMed ID: 15578103
    [Abstract] [Full Text] [Related]

  • 17. Enzyme replacement therapy with imiglucerase in a Taiwanese child with type 1 Gaucher disease.
    Lin HY, Lin SP, Chuang CK, Wraith JE.
    J Chin Med Assoc; 2006 May 15; 69(5):228-32. PubMed ID: 16835986
    [Abstract] [Full Text] [Related]

  • 18. Initiation treatment with imiglucerase every 3 weeks in type 1 Gaucher disease.
    Serratrice C, Swiader L, Serratrice J, Weiller PJ, Verrot D.
    Eur J Intern Med; 2012 Mar 15; 23(2):e71-2. PubMed ID: 22284262
    [No Abstract] [Full Text] [Related]

  • 19. Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.
    Grabowski GA, Kacena K, Cole JA, Hollak CE, Zhang L, Yee J, Mistry PK, Zimran A, Charrow J, vom Dahl S.
    Genet Med; 2009 Feb 15; 11(2):92-100. PubMed ID: 19265748
    [Abstract] [Full Text] [Related]

  • 20. Reduction in imiglucerase dosage causes immediate rise of chitotriosidase activity in patients with Gaucher disease.
    Chien YH, Lee NC, Tsai FJ, Chao MC, Hwu WL.
    Mol Genet Metab; 2010 Sep 15; 101(1):90-1. PubMed ID: 20580583
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.